Work

The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR

Year: 2006

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdl357

Authors: J. Pfisterer, A. du Bois, J. Sehouli, S. Loibl, S. Reinartz, A. Reuß, U. Canzler, A. Belau, C. Jackisch, R. Kimmig, K. Wollschlaeger, V. Heilmann, F. Hilpert

Institutions: University Hospital Schleswig-Holstein, Helios Dr. Horst Schmidt Kliniken Wiesbaden, Charité – Universitätsmedizin Berlin, Goethe University Frankfurt, University Hospital Frankfurt, Universitätsklinikum Gießen und Marburg, Philipps University of Marburg, University Hospital Carl Gustav Carus, Universität Greifswald, Essen University Hospital, Otto-von-Guericke-Universität Magdeburg, University Hospital Ulm

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2116819476

FWCI: 6.006

Cites: 34

Cited by: 64

Related to: 10